NERLSCD 2026 – Worcester
biomodal is proud to sponsor the 2026 NERLSCD Annual Meeting, taking place October 14-16 at Worcester Polytechnic Institute in Worcester, MA. NERLSCD brings together core facility directors, managers, and staff from academic institutions across North America for two days of science, networking, and learning about the latest advances in biotechnology. Stop by our table and […]
ICR Postdoc Away Day 2026
🎤 Join biomodal’s talk with Leonardo Motta to discover how our next‑generation multiomic technologies bring clarity to complex biology. In this talk, Leonardo will showcase duet™ cfDNA, a fully integrated genetic and epigenetic workflow designed specifically for low‑input cfDNA applications. By capturing a complete set of biomarkers—including genetic variants, 5mC and 5hmC, and fragmentomic information—from […]
QMUL Centre for Epigenetics Symposium 2026
This in person only event will provide a platform for world-renowned scientists to share and discuss the recent advances in the field, with a particular focus on disease, evolution and development, repetitive elements, and the latest applications of artificial intelligence and computational tools in epigenetics research. 🎤 Join biomodal’s talk with Leonardo Motta to discover […]
ESHG 2026
biomodal will be represented at this year’s ESHG conference in collaboration with our Certified Service Provider, Life & Brain. As one of the most influential gatherings for human genetics in Europe, ESHG brings together experts from research, clinical practice, diagnostics, public health, and related disciplines, fostering exchange across diverse backgrounds and international perspectives. Attendees can […]
AICC 2026
Chromatin research across Ireland is advancing rapidly – powered by a thriving scientific community, cutting‑edge technologies, and a collaborative spirit that spans institutions. The All‑Ireland Chromatin Consortium (AICC) Annual Meeting brings this community together for a one‑day forum dedicated to accelerating discovery and strengthening connections in chromatin biology. Hosted at the Conway Institute, UCD, the […]
CLEPIC
CLEPIC2026 will gather leading experts, clinicians, and industry innovators to share the latest advances in molecular and clinical epigenetics, with a special focus on cancer epigenetics. We would also like to invite you to join our session “The 6-base genome unlocks novel mechanistic biomarkers and enhanced biological insight from challenging clinical samples”, where biomodal’s Scientific Affairs […]
ImmunoMemphis 2026
Harmonizing Immunotherapy: Tuning T Cells to Give Cancer the Blues Meet biomodal at ImmunoMemphis Understanding T cell immunity from differentiation to durable tumor control requires more than single-dimensional data. biomodal works alongside researchers to reveal the epigenetic and transcriptomic layers that drive meaningful biological insight, helping translate discovery into therapeutic impact. Mark Consugar and Christine […]
Canadian Conference on Circulating Biomarkers (CCCB) 2026
biomodal is proud to sponsor the 2026 Canadian Conference on Circulating Biomarkers (CCCB), the inaugural national meeting hosted by the RI‑MUHC Circulating Biomarkers of Health and Disease Research Network. Established to advance research on circulating biomarkers across health and disease, the RI‑MUHC network brings together researchers, clinicians, trainees, and patient partners from the Research Institute […]
SSMG 2026
biomodal will be represented at this year’s SSMG Annual Meeting in collaboration with our Certified Service Provider, Life & Brain. The SSMG agenda features topics including long read sequencing, non coding variants, inherited metabolic disorders, and complex trait genetics, alongside poster sessions, industry exhibitions, and networking opportunities. Throughout the event, biomodal will be present at the […]
EACR Congress 2026
Meet biomodal at the EACR Congress 2026 biomodal is excited to be part of the European Association for Cancer Research (EACR) Congress 2026, a leading international forum bringing together the cancer research community to share cutting‑edge science, emerging technologies, and new translational insights. Visit biomodal at Booth 53 to learn why genetics alone doesn’t tell […]